Vera Therapeutics

Vera Therapeutics(VERA)

BRISBANE, CA
Biotechnology

Focus: Gene Editing Technology

Vera Therapeutics is a life sciences company focused on Gene Editing Technology.

Gene Therapy
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
13

Pipeline & Clinical Trials

Specialized Early Engagement Support Service
First-Episode Psychosis
N/A
Clinical Trials (1)
NCT03962348Clinical Interviews With Detainees With Early Psychosis
N/A
Prone position
Prone Position
N/A
Clinical Trials (1)
NCT07251777Prone vs Supine Position in Potential Organ Donors: Multicenter Clinical Trial
N/A
Provision of information on safe water
Child Malnutrition
N/A
Clinical Trials (1)
NCT02427945Leveraging an Existing Large-scale Safe Water Program to Deliver Nutrition Messages at a Low Marginal Cost
N/A
Clinical Trials (1)
NCT03525990Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients
N/A
Nitazoxanide Tablets
COVID-19
N/A
Clinical Trials (1)
NCT04348409Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19
N/A
Lung Perfusion Measured With Dual-Energy CT in Patients With Chronic Thromboembolic Pulmonary Hypert
Multidetector Computed Tomography
N/A
Clinical Trials (1)
NCT03450304Lung Perfusion Measured With Dual-Energy CT in Patients With Chronic Thromboembolic Pulmonary Hypertension: Comparative Study With Right Heart Catheterization and V/Q
N/A
Virtual reality glasses
Anxiety
N/A
Clinical Trials (1)
NCT07270445Effect of Virtual Reality Use on Preoperative Anxiety
N/A
Peri-Transfusion QOL Assessment
Myelodysplastic Syndromes
N/A
Clinical Trials (1)
NCT03660228Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS
N/A
Assessment of Preoperative Anxiety and Evaluation of Calming Interventions: Anonymous Patient Survey
Anxiety
N/A
Clinical Trials (1)
NCT07291466Assessment of Preoperative Anxiety and Evaluation of Calming Interventions: Anonymous Patient Survey
N/A
Targeted Educational Campaign
Work-Related Condition
N/A
Clinical Trials (1)
NCT05451225Survey of Correction Officers Before and After a Targeted Education Campaign
N/A
Clinical Trials (1)
NCT03060018Transcutaneous Partial Oxygen and Carbon Dioxide Pressures Compared With Blood Gas Values
N/A
Phase 2
Clinical Trials (1)
NCT04294472A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients
Phase 2
Analogs, Prostaglandin E1
Covid19
Phase 2
Clinical Trials (1)
NCT04536363Cri Analog PG1 Effectiveness and Safety in Covid-19
Phase 2
NestaCell®
COVID-19 Pneumonia
Phase 2
Clinical Trials (1)
NCT04315987NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia
Phase 2
Genomically Directed Monotherapy
Malignant Neoplasm of Breast
Phase 2
Clinical Trials (1)
NCT02101385Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Phase 2
Atacicept 150 mg
IgA Nephropathy (IgAN)
Phase 2
Clinical Trials (1)
NCT06674577A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
Phase 2
Phase 2
Clinical Trials (1)
NCT07020923Monthly Dosing of Atacicept in IgAN
Phase 2
Atacicept
pMN
Phase 2
Clinical Trials (1)
NCT06983028Atacicept in Multiple Glomerular Diseases
Phase 2
Capecitabine
Breast Cancer
Phase 2
Phase 3
Clinical Trials (1)
NCT04716231Atacicept in Subjects With IgA Nephropathy
Phase 3
Phase 3
Clinical Trials (1)
NCT05609812Atacicept in Subjects With Active Lupus Nephritis (COMPASS)
Phase 3
Immune Globulin 10% Intravenous Solution
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 3
Clinical Trials (1)
NCT03166527Panzyga in CIDP Administered at Different Infusion Rates
Phase 3
CYP2C19 genotyping
Myocardial Infarction
Phase 4
Clinical Trials (1)
NCT01761786Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics)
Phase 4
Experimental: Hyperslim
Venous Thromboembolism (VTE)
Phase 4
Clinical Trials (1)
NCT06958588Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Phase 4

Open Jobs (13)

Interview Prep Quick Facts
Founded: 1980
Portfolio: 23 clinical trials
Top TAs: Nephrology, Immunology
SEC Filings: 2 available
Open Roles: 13 active jobs
Therapeutic Area Focus
Nephrology
4 pipeline
Immunology
1 pipeline
Marketed
Pipeline

Financials (FY2025)

R&D Spend
$78M0%
Net Income
-$96M
Cash
$93M

Hiring Trend

Stable
13
Open Roles
+3
Added
-1
Filled/Removed

Based on last 4 crawl cycles